Hunan Jiudian Pharmaceutical Co., Ltd.

XSEC:300705 Stock Report

Market Cap: CN¥11.5b

Hunan Jiudian Pharmaceutical Future Growth

Future criteria checks 4/6

Hunan Jiudian Pharmaceutical is forecast to grow earnings and revenue by 25.5% and 18.1% per annum respectively. EPS is expected to grow by 25.2% per annum. Return on equity is forecast to be 24.4% in 3 years.

Key information

25.5%

Earnings growth rate

25.2%

EPS growth rate

Pharmaceuticals earnings growth18.8%
Revenue growth rate18.1%
Future return on equity24.4%
Analyst coverage

Good

Last updated06 Nov 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

XSEC:300705 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20264,4368745428876
12/31/20253,7506733696347
12/31/20243,1625212796237
9/30/20242,945508235646N/A
6/30/20242,841455286652N/A
3/31/20242,782417192571N/A
12/31/20232,6933684431N/A
9/30/20232,62037160490N/A
6/30/20232,513338-86427N/A
3/31/20232,379291-162369N/A
1/1/20232,326270-144269N/A
9/30/20222,097243-55262N/A
6/30/20221,927221-16163N/A
3/31/20221,79921457176N/A
1/1/20221,62820465191N/A
9/30/20211,45119641149N/A
6/30/20211,31716248166N/A
3/31/20211,09612263148N/A
12/31/20209788272150N/A
9/30/20209217283183N/A
6/30/20208915931144N/A
3/31/202090652-15127N/A
12/31/201992455-9191N/A
9/30/201990065-16264N/A
6/30/201986773-17662N/A
3/31/201981170-20076N/A
12/31/201880172-18968N/A
9/30/201874667-16040N/A
6/30/201868072N/A65N/A
3/31/201861371N/A56N/A
12/31/201753569N/A80N/A
9/30/201747272N/A86N/A
6/30/201743062N/A75N/A
3/31/201738556N/A52N/A
12/31/201637655N/A55N/A
9/30/201633439N/A35N/A
6/30/201632038N/A32N/A
3/31/201630541N/A32N/A
12/31/201529045N/A32N/A
9/30/201528143N/A30N/A
6/30/201527240N/A28N/A
3/31/201526941N/A34N/A
12/31/201426641N/A40N/A
12/31/201324136N/A31N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 300705's forecast earnings growth (25.5% per year) is above the savings rate (2.8%).

Earnings vs Market: 300705's earnings (25.5% per year) are forecast to grow slower than the CN market (26.2% per year).

High Growth Earnings: 300705's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 300705's revenue (18.1% per year) is forecast to grow faster than the CN market (13.9% per year).

High Growth Revenue: 300705's revenue (18.1% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 300705's Return on Equity is forecast to be high in 3 years time (24.4%)

Discover growth companies

7D

1Y

7D

1Y

7D

1Y